Katten Muchin Rosenman has advised Processa Pharmaceuticals, Inc. Cooley has advised Vidya Therapeutics, Inc. Mintz has advised the placement agents. Processa Pharmaceuticals, Inc. (NASDAQ: PRCT) has...
Processa Pharmaceuticals Acquires Vidya Therapeutics and Announces $200 Million Private Placement
Processa Pharmaceuticals’ $6.25 Million Common Stock Offering
Foley & Lardner represented Processa Pharmaceuticals, while Sichenzia Ross Ference represented Spartan Capital Securities in the offering. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), a diversified clinical-stage company...